Free Submission Public Relations &
Deutsch English

Global Chiral Technology Market 2012-2016

Global chiral technology market: 7% CAGR between 2012-2016

Print article Print article
2014-02-26 04:56:03 - Global Chiral Technology Market 2012-2016 - a new market research report on

The Global Chiral Technology market is to grow at a CAGR of 6.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is favorable government regulations for chiral technology. The Global Chiral Technology market has also been witnessing increasing reliance on generic approaches. However, the slow commercialization of chiral technology-based products could pose a challenge to the growth of this market.

The Global Chiral Technology market is witnessing an increase in mergers and acquisitions. Vendors are adopting the mergers and acquisitions strategy to increase their global presence and expand their product portfolio, as well as to achieve economies of scale. Vendors can focus better on product innovations and increase their profit margins by collaborating with



each other. For instance, on August 8, 2012, Royal DSM announced that it had entered into an agreement to acquire Tortuga Companhia Zootecnica Agraria, a Brazilian company involved in the manufacturing of nutritional supplements for animals. The increase in such acquisitions boosts the growth of the Global Chiral Technology market.

The presence of favorable government regulations promoting the use of chiral technology is one of the major drivers of the market. Healthcare authorities across the globe have introduced guidelines and policies to provide incentives and thus encourage investments for the development of single-enantiomer drugs.

One of the major challenges in the market is the snail-paced commercialization of chiral technology-based drugs and chemicals. This factor has adversely affected the adoption of chiral technology.

The key vendors dominating this space are Daicel Corp., Chiral Technologies, Royal DSM N.V., and Sigma Aldrich Corp. The other vendors mentioned in the report are Albemarle Corp., BASF SE, Cambrex Corp., Chiral Quest Inc., Regis Technologies Inc., and Shasun Pharmaceuticals Ltd.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact